In summary, we demonstrate that dermal TRMs orchestrate localized type 2 circuitries with ILC2s and eosinophils, mediated by TSLP and CCL24 respectively, to promote non-healing cutaneous leishmaniasis. Here, TSLP is linked to cutaneous leishmaniasis.